Biodesix Inc

General ticker "BDSX" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $200.0M (TTM average)

Biodesix Inc does not follow the US Stock Market performance with the rate: -0.8%.

Estimated limits based on current volatility of 4.6%: low 0.55$, high 0.60$

Factors to consider:

  • Current price 31.6% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.84$, 2.26$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.85$, 2.32$]

Financial Metrics affecting the BDSX estimates:

  • Negative: Non-GAAP EPS, $ of -0.35 <= 0.04
  • Negative: Operating cash flow per share per price, % of -21.32 <= 1.79
  • Positive: -0.29 < Industry operating profit margin (median), % of 0.23
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of 21.47 <= 22.52
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of -3.09 <= -1.01
  • Negative: Industry earnings per price (median), % of 0.85 <= 3.66

Similar symbols

Short-term BDSX quotes

2025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-150.50.550.60.650.70.750.80.850.90.95
Price $

Long-term BDSX plot with estimates

0.511.522.5Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.15−0.1−0.050
BDSXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $38.21MM $49.09MM $71.32MM
Operating Expenses $88.72MM $90.43MM $105.82MM
Operating Income $-50.51MM $-41.34MM $-34.50MM
Non-Operating Income $-14.94MM $-10.80MM $-8.43MM
Interest Expense $8.07MM $9.54MM $8.26MM
R&D Expense $13.10MM $9.99MM $9.56MM
Income(Loss) $-65.45MM $-52.15MM $-42.93MM
Profit(Loss)* $-80.39MM $-52.15MM $-42.93MM
Stockholders Equity $20.61MM $4.58MM $20.88MM
Inventory $1.40MM $1.40MM $0.00MM
Assets $92.91MM $99.10MM $97.24MM
Operating Cash Flow $-44.97MM $-22.87MM $-48.65MM
Capital expenditure $3.53MM $23.06MM $3.23MM
Investing Cash Flow $-3.53MM $-23.06MM $-3.44MM
Financing Cash Flow $58.88MM $29.13MM $52.05MM
Earnings Per Share** $-1.91 $-0.64 $-0.33

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.